chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a consumer's husband refers to his 81 year old wife with high blood pressure and cholesterol. The patient's medical history included ulcer and thyroid disorder (unspecified reported as thyroidn). No drug reactions/allergies were reported. On an unknown date in August 2008 (reported as five years ago), the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiry not reported) in the left arm. No concomitant medications were reported (reporter did not known names of the medication). On an unknown date in April 2013, the patient came down with shingles. Shingles came around from the back to the left breast. The reporter stated he was not aware you could get shingles after taking the vaccine. No laboratory test were performed. The outcome of shingles was unknown. Additional information has been requested.
arm and neck immobility; Inflammatory flareups; knee pain; my neck and shoulder stiffened; Joint stiffness; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 5318; DOSE NUMBER: 1) via unspecified route of administration in the left arm on 22Feb2021 at 16:15 (at the age of 45-year-old) as 1st dose single for COVID-19 immunisation. Medical history of the patient included Herpes simplex type 2 (hsv-2) and bulging disks. The patient had gluten sensitivity, yeast and onion allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient was not tested with COVID-19. Concomitant medications were reported as using other medication in 2 weeks. The patient had not received any other vaccine 4 weeks prior to vaccination. On 23Feb2021, the patient had inflammatory flare ups, neck and shoulder stiffened, knee pain and joint stiffening, arm and neck immobility. Events resulted Doctor or other healthcare professional office/clinic visit. The patient received chiropractic adjustment, massage and physical treatment (PT) for the event. The outcome of the events inflammatory flare ups, neck and shoulder stiffness, knee pain and joint stiffening, arm and neck immobility was recovering. No follow-up attempts are possible. No further information is expected
breakthrough COVID-19; This literature-study case was reported in a literature article and describes the occurrence of COVID-19 (breakthrough COVID-19) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.   LITERATURE REFERENCE: (PRIVACY)    The patient's past medical history included Stem cell transplant (Auto HSCT (allogeneic hematopoietic stem cell transplant recipient) was treatment given.). Concurrent medical conditions included Multiple myeloma.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (breakthrough COVID-19) (seriousness criterion hospitalization). At the time of the report, COVID-19 (breakthrough COVID-19) outcome was unknown. Possible    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood immunoglobulin G: 0.075 0.075 Post-vaccination and 3096.9 3096.9 Post-vaccination. On an unknown date, SARS-CoV-2 antibody test positive: positive (Positive) SARS CoV 2 RNA, RT PCR.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered COVID-19 (breakthrough COVID-19) to have an unknown relationship.    Concomitant product and treatment medication use was not provided by the reporter.  This literature report case concerns a 75 year-old male with a history of multiple myeloma and  Auto HSCT (allogeneic hematopoietic stem cell transplant); who experienced the  unexpected serious (as per hospitalization) AESI event of COVID-19.  The event started 194 days after the second dose of an unknown product administration schedule of mRNA-1273 vaccine. The outcome of the event is unknown. The rechallenge is not applicable. The medical history of Multiple myeloma and transplantation are relevant predisposing factors for the event COVID-19. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report; Sender's Comments: This literature report case concerns a 75 year-old male with a history of multiple myeloma and  Auto HSCT (allogeneic hematopoietic stem cell transplant); who experienced the  unexpected serious (as per hospitalization) AESI event of COVID-19.  The event started 194 days after the second dose of an unknown product administration schedule of mRNA-1273 vaccine. The outcome of the event is unknown. The rechallenge is not applicable. The medical history of Multiple myeloma and transplantation are relevant predisposing factors for the event COVID-19. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report
I'm 56 and  very healthy, never sick, never take meds and see a doctor for well-woman only. 3-4 weeks after the 2nd dose I started feeling my hands and feet were swollen and very painful to bend.  It really hit me on March 28, 2021 I couldn't grab my sheets/blankets when I was cold and My feet hurt so badly I could barely walk.  Also, I was very tired, dry eyes, dry mouth,  A friend of mine said it sounded like rheumatoid arthritis.  I researched it and went to doctor on March 29.  She knows I've been healthy and laughed at my self-diagnosis.  I have no family history of RA.  I told my doctor I thought I got this because of the vaccine.   My doctor ordered x-rays and blood work.  On March 31st she called me and said my  RF and CCP were off the charts, that I have RA and that I need to see a rheumatologist.
Patient was telling nurse how the HPV hurt more than the MENACTRA and then passed out and patient started shaking. Was passed out for a minute or two and then responsive to questions but very drowsy and laid down. Continue to monitor 30 mins with after injections.
An MMR II vaccine was administered today after it had expired; This spontaneous report was received from a registered medical assistant and refers to a female patient of unknown age. No information regarding the patient's concurrent conditions, medical history, drug reactions or allergies and concomitant medications was provided.  On 24-NOV-2020, the patient was vaccinated with expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot # R031636, expiration date 01-NOV-2020 (exact dose, vaccination site and route of administration were not provided) for prophylaxis.
Pt received .5ml, SC, vaccination of Menomune Meningococcal upper R arm. Mother stated that usually 4 nurses need to restrain pt in order for him to get a shot. Pt took the shot without any restraint and pt stayed in room talking with me for 15 minutes and then he and his mother and brother left the office. Brother returned to office stating his brother wasn't feeling well. Pt was sitting in hallway stating he was "dizzy, felt numb all over and slightly nauseated". The pt was pale, slightly tremulous and diaphoretic. Pt's pulse was 64 and regular. Pt was assisted into wheelchair and returned to office where he was assisted onto pt exam couch. Pt was observed for about 15 minutes, in which time he was allowed to sip some water and sit upright. Pt's color returned. Pt's pulse rate remained stable, and his diaphoresis ended. Pt remained sitting and stated he was no longer dizzy, tremulous or nauseated. Pt left office with his mother and brother. Pt and pt's mother were instructed to contact their physician if symptoms returned.
Itching immediately, swelling, sore & painful, travel down to elbow, continue to get red & bruised.
1 inch by 2 inch swollen, firm, red, tender  area at injection site in left upper arm. In left armpit, a swollen and tender lymph node
The patient received the vaccination on Monday. Her symptoms began on Tuesday. The patient experienced puffy, redness around the injection site. On Thursday the patient saw the Dr and was started on Prednisone and Atarax. Sunday was her worst day, with a rash covering nearly all of her body, but heaviest around the injection site. On Tuesday the patient saw the Dr and was prescribed Prednisone, Zyrtec and Atarax. 12/17/2001 Site has nodule remaining.
Developed a cough approximately three days after shot; Had intense pain in feet and ankles; Felt like bones were breaking when I walked; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208), via an unspecified route of administration in the left arm on 12Mar2021 at 10:00 (at the age of 61-years-old), as a single dose for COVID-19 immunisation. Medical history included high cholesterol, hypothyroidism, mild osteopenia, depression and shellfish allergy. Concomitant medications included rosuvastatin (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN) and calcium gluconate (CALCIUM); all from unknown dates for unspecified indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Mar2021 at 08:00, approximately three days after shot, the patient developed a cough, had intense pain in feet and ankles for three days straight. The patient felt like bones were breaking when walked. Subsided gradually but still had a little pain three weeks later. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. On 29Mar2021, the patient underwent SARS-CoV-2 test and the result was negative. The clinical outcome of the events cough, intense pain in feet and ankles for three days and felt like bones were breaking when walked were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Pt presented with HIVES and itching after Flu Vaccine given about 20 minutes after vaccine.Pt given 50 mg IM of Benadryl.  Pt monitored for 30 minutes after reaction.  Pt ambulated to vehicle, husband drove home, no further problems.  Counseled on S/SX to watch for and when to present to ER.
This spontaneous report was received from a healthcare worker and refers to unspecified number of patients of unknown age and gender. No information about patients' pertinent medical history, concurrent conditions, concomitant medications, drug reactions or allergies was provided. On unspecified dates, the patients were administered doses of PNEUMOVAX 23 lot # K010466, expiration date 23-MAR-2016 (dose and route of administration were not reported) which were exposed to temperatures outside of the recommended range. No adverse experience was reported. This is one of several reports from the same reporter. Additional information has been requested.
Information regarding Flumist (2003-2004 Formula) (influenza virus vaccine, live intranasal (2003-2004 formula) nasal solution (frozen)) was received from a healthcare professional regarding a pt who experienced liquid running down the back of the throat that tasted bad and was irritating.  The pt received a dose on 10/07/03.  The reporter indicated that two pt's experienced this event; however, they are not presently identifiable.  Additional reports will be generated when identifying information is provided.  No additional information was available at the date of this report.
Unable to sleep; Body aches; Fever; Cough; Chest pain; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 16:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and penicillin allergy. The patient previously received acetylsalicylic acid (ASPIRIN) on an unspecified date, for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not take concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 17:00 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. On 20Apr2021 at 21:00, the patient reported that she was unable to sleep, had body aches, fever, cough and chest pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events unable to sleep, body aches, fever, cough and chest pain was recovered on an unknown date in  Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Localized injection site reaction on day 6, including itch and burning pain, cellulitis appearing reaction, redness, hardness developed on day 7, redness continuing on day 8, 9, 10 with soreness, itching and arm pain.
Patient developed fever to 102 per mother approximately 11 hours after vaccine given, vomited once, and had seizure about 9 hours after fever noted.  Mother reported giving Tylenol for fever.  Patient was taken to ER after seizure, where it was assumed to be febrile seizure. Patient has history of febrile seizure.
sore arm; funny taste in mouth; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and TASTE DISORDER (funny taste in mouth) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 002A21A) for COVID-19 vaccination.     The patient's past medical history included Resistant hypertension, Vertigo (unbalance, vertigo, double vision, headaches.), Cardiac catheterisation in 2014, Kidney atrophy, Arterial stenosis, Autoimmune disorder (Mixed connective tissue disease), Hashimoto's disease and Lichen sclerosis atrophicus. Previously administered products included for an unreported indication: PNEUMO 23 (PPS23). Concurrent medical conditions included Allergy to antibiotic (sulfa, ), Allergy to antibiotic (chlorthalidone), Contrast media allergy and Reaction to vaccine preservatives (Reaction to PEG). Concomitant products included AMLODIPINE BESILATE (NORVASC) for Angina syndrome, METOPROLOL for Arrhythmia, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for Coronary artery disease, LOSARTAN POTASSIUM (COZAAR) for Hypertension, APIXABAN (ELIQUIS) for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and TASTE DISORDER (funny taste in mouth). At the time of the report, PAIN IN EXTREMITY (sore arm) and TASTE DISORDER (funny taste in mouth) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: high (High) 168 over ?. On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.         No treatment medications were reported   This case was linked to MOD-2021-073821 (Patient Link).
Client tested positive for COVID-19 on 04/17/21.  Client states that they are asymptomatic.  Client is being followed by a case manager with the Health Dept.
This is a spontaneous report received from a contactable consumer or other non-HCP (patient). A 31-year-old patient received the 1st dose of BNT162B2 (Comirnaty, batch/lot# unknown), single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient had vaccination site pain/soreness around the injection spot, with outcome of unknown. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Right upper arm started to swell and became itchy the day after (day 2) receiving menactra vaccine.  No pain.  Right upper arm & 1/2 lower arm swollen on the following day (day 3).
My arm swollen  from my shoulder to my elbow. My doctor stated its cellulitis.
Headache, Myalgia, Arthralgia, lymphedema, sore arm, fatigue, tinnitus Narrative:  2nd dose: myalgia, lymphedema, arthralgia, fatigue, headache, fever, white noise in bilateral ears for 15 minutes.
Fibro myalgia pain severe.  Can?t walk.  Pain in lower back and neuropathy pain in extremities
She described that she could "feel" the vaccine in her mouth, but stated that she did not have any difficulty breathing. I told her she could take Benadryl if she felt it necessary and to discuss reveicing the 2nd dose with her PCP
Child received 4 month immunizations yesterday 8/22/2022, received Pentacel, Prevnar 13 and Rotarix.  This morning woke up with hives covering entire body, there was a noticeable area of hives where the Prevnar 13 was given in the left thigh however I understand she received multiple vaccines.  The Parents also state she was quite lethargic yesterday and slept most of the day and all night last night.   When the child received her 2 month vaccines she was given Pediarix, Hiberix, Rotarix and Prevnar 13 and did not experience any difficulties.
Since he got first shot when he goes on treadmill his heart rate goes up and down; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE IRREGULAR (Since he got first shot when he goes on treadmill his heart rate goes up and down) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEART RATE IRREGULAR (Since he got first shot when he goes on treadmill his heart rate goes up and down). At the time of the report, HEART RATE IRREGULAR (Since he got first shot when he goes on treadmill his heart rate goes up and down) had not resolved.            No concomitant medications were provided. Patient received 3 full doses of the Moderna vaccine. It was reported that the patient wore chest strap and it was linked to phone where he could see heart rate and doctors could not find anything wrong. The patient did not had chest pain. No treatment medications were provided.   Reporter did not allow further contact
sinus congestion; headache; slight nausea; Chills; Swollen lymph gland on left side of neck just above collar bone; This is a spontaneous report from a contactable consumer or other non-healthcare professional (Patient). A 67-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9267), second dose via an unspecified route of administration, administered in left arm on 14Feb2021 at 15:30 (at the age of 67-year-old) as dose 2, single for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease from an unknown date and unknown if ongoing. Concomitant medications in 2 weeks of COVID-19 vaccination included simvastatin (SIMVASTATIN) taken for an unspecified indication, start and stop date were not reported; zolmitriptan (ZOMIG) taken for an unspecified indication, start and stop date were not reported; nadolol (NADOLOL) taken for an unspecified indication, start and stop date were not reported; famotidine (FAMOTIDINE) taken for an unspecified indication, start and stop date were not reported. Historical vaccine given to patient previously was bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: unknown), first dose via an unspecified route of administration, administered in left arm on 24Jan2021 at 13:30 (at the age of 67-year-old) as dose 1, single for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 15Feb2021, the patient experienced swollen lymph gland on left side of neck just above collar bone. Chills, slight nausea, headache, sinus congestion. No treatment was received for the events. The outcome of the events was reported as resolving.  Follow-up attempts completed. No further information expected.
fever; Vomiting; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), VOMITING (Vomiting) and MYALGIA (Muscle aches) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Diabetic. Concomitant products included INSULIN and METFORMIN for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), VOMITING (Vomiting) and MYALGIA (Muscle aches). At the time of the report, PYREXIA (fever), VOMITING (Vomiting) and MYALGIA (Muscle aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication was reported.
DtaP, Varicella received right arm 1/12/05. 1/14/05 patient brought to clinic with erythema, swelling, tenderness and rash at site of injection.  Night time fever reported by caregiver.  Symptoms reported to have started the evening of the 13th.  Diagnosed by physician as allergic reaction to vaccination with potentially superimposed infection.  Treatment included Benadryl and Augmentin for 5 days.  Kenalog cream to rash BID until clear.  Caregiver talked to on 1/24/05 - she reported child's arm resolved without problem.